{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:16:54Z","timestamp":1794626214765,"version":"4.9.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Taiwan Ministry of Health and Welfare Clinical Trial Center","award":["MOHW109-TDU-B-212-114004"],"award-info":[{"award-number":["MOHW109-TDU-B-212-114004"]}]},{"name":"China Medical University Hospital in Taiwan","award":["DMR109-098"],"award-info":[{"award-number":["DMR109-098"]}]},{"name":"MOST Clinical Trial Consortium for Stroke","award":["MOST 108-2321-B-039-003"],"award-info":[{"award-number":["MOST 108-2321-B-039-003"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Inflammatory bowel disease is associated with an increased risk of opportunistic infections. This study aimed to investigate the incidence rate of herpes zoster in patients with inflammatory bowel disease.<\/jats:p>\n                    <jats:p>A meta-analysis was conducted by searching PubMed literature published from January 2000 to July 2019. The main outcome was the incidence rate of a new diagnosis of herpes zoster in patients previously diagnosed with inflammatory bowel disease. The incidence rate ratio (IRR) and 95% confidence interval (95% CI) for herpes zoster associated with inflammatory bowel disease was measured.<\/jats:p>\n                    <jats:p>A total of 6 eligible cohort studies matching the entry criteria were included in the meta-analysis, providing 216,552 participants with inflammatory bowel disease and 790 events of herpes zoster among these participants with inflammatory bowel disease. The pooled incidence rate of developing herpes zoster was 10.41 per 1000 person-years in the inflammatory bowel disease group and 6.10 per 1000 person-years in the non-inflammatory bowel disease group, respectively. The meta-analysis demonstrated that patients with inflammatory bowel disease were associated with 1.68-fold increased risk of developing herpes zoster when compared to those without inflammatory bowel disease (IRR\u200a=\u200a1.68, 95% CI\u200a=\u200a1.53\u20131.84). Crohn disease and ulcerative colitis were associated with an increased risk of developing herpes zoster (IRR\u200a=\u200a1.67, 95% CI\u200a=\u200a1.40\u20131.98 for Crohn disease and IRR\u200a=\u200a1.49, 95% CI\u200a=\u200a1.34\u20131.65 for ulcerative colitis, respectively).<\/jats:p>\n                    <jats:p>Patients with inflammatory bowel disease are at increased risk of developing herpes zoster. We suggest that the vaccination should be considered at the time of inflammatory bowel disease being diagnosed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000026863","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T09:09:33Z","timestamp":1629450573000},"page":"e26863","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["The incidence rate of herpes zoster in inflammatory bowel disease"],"prefix":"10.1097","volume":"100","author":[{"given":"Shih-Wei","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Public Health, College of Public Health, and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan"},{"name":"Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Fu","family":"Liao","sequence":"additional","affiliation":[{"name":"College of Medicine, Tzu Chi University, Hualien, Taiwan"},{"name":"Division of Hepatogastroenterology, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Li","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan"},{"name":"Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hung","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Research, Taichung Tzu Chi Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Shong","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan"},{"name":"Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Fang","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Occupational Safety and Health, College of Public Health, China Medical University, Taichung, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3810\/pgm.2013.09.2703","article-title":"Herpes zoster: diagnostic, therapeutic, and preventive approaches","volume":"125","author":"Bader","year":"2013","journal-title":"Postgrad Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/00325481.2017.1335574","article-title":"Herpes zoster - typical and atypical presentations","volume":"129","author":"Dayan","year":"2017","journal-title":"Postgrad Med"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"ITC19","DOI":"10.7326\/L18-0558","article-title":"Herpes zoster","volume":"169","author":"Schmader","year":"2018","journal-title":"Ann Intern Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/jhbp.575","article-title":"Chronic pancreatitis correlates with increased risk of herpes zoster in a population-based retrospective cohort study","volume":"25","author":"Lai","year":"2018","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s41999-018-0096-5","article-title":"Case\u2013control study examining the association between herpes zoster and oral corticosteroids use in older adults","volume":"9","author":"Lai","year":"2018","journal-title":"Eur Geriatr Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"k5095","DOI":"10.1136\/bmj.k5095","article-title":"Herpes zoster infection","volume":"10","author":"Le","year":"2019","journal-title":"BMJ"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/apt.14171","article-title":"Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease","volume":"46","author":"Alexakis","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jcag\/gwy025","article-title":"Incidence of suicide in inflammatory bowel disease: a systematic review and meta-analysis","volume":"1","author":"Zhang","year":"2018","journal-title":"J Can Assoc Gastroenterol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/jamadermatol.2019.0891","article-title":"Association of hidradenitis suppurativa with inflammatory bowel disease: a systematic review and meta-analysis","volume":"155","author":"Chen","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1097\/MIB.0000000000000902","article-title":"Management and prevention of herpes zoster in the immunocompromised inflammatory bowel disease patient: a clinical quandary","volume":"22","author":"Cote-Daigneault","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R12-20250504","first-page":"415","article-title":"Infections in inflammatory bowel disease","volume":"148","author":"Rodriguez de Santiago","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/17474124.2018.1530983","article-title":"The risk for opportunistic infections in inflammatory bowel disease with biologics: an update","volume":"12","author":"Borman","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1159\/000489643","article-title":"Prevention of infectious diseases due to immunosuppression and vaccinations in Asian patients with inflammatory bowel disease","volume":"3","author":"Sagami","year":"2018","journal-title":"Inflamm Intest Dis"},{"key":"R15-20250504","first-page":"247","article-title":"Improving immunization strategies in patients with inflammatory bowel disease","volume":"32","author":"Farshidpour","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cgh.2006.09.019","article-title":"Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease","volume":"4","author":"Gupta","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/apt.12182","article-title":"Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease","volume":"37","author":"Long","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijcp.12508","article-title":"Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study","volume":"69","author":"Tsai","year":"2015","journal-title":"Int J Clin Pract"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.cgh.2017.12.052","article-title":"Overall and comparative risk of herpes zoster with pharmacotherapy for inflammatory bowel diseases: a nationwide cohort study","volume":"16","author":"Khan","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.cgh.2018.05.024","article-title":"Increased risk of herpes zoster infection in patients with inflammatory bowel diseases in Korea","volume":"16","author":"Chang","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5009\/gnl18304","article-title":"Increased risk of herpes zoster in young and metabolically healthy patients with inflammatory bowel disease: a nationwide population-based study","volume":"13","author":"Soh","year":"2019","journal-title":"Gut Liver"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ibd\/izy311","article-title":"Herpes zoster incidence in inflammatory bowel disease patients: a population-based study","volume":"25","author":"Cote-Daigneault","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"582","DOI":"10.5009\/gnl19141","article-title":"Inflammatory bowel disease and the risk of herpes zoster","volume":"13","author":"Lai","year":"2019","journal-title":"Gut Liver"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1093\/ibd\/izz141","article-title":"Increased incidence of herpes zoster infection in patients with inflammatory bowel disease","volume":"25","author":"Liao","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1093\/jtm\/tax082","article-title":"Safety of live vaccines on immunosuppressive or immunomodulatory therapy-a retrospective study in three Swiss Travel Clinics","volume":"25","author":"Huber","year":"2018","journal-title":"J Travel Med"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/MIB.0000000000000743","article-title":"Herpes zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression","volume":"22","author":"Wasan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/apt.14257","article-title":"Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications","volume":"46","author":"Khan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG Clinical Guideline: preventive care in inflammatory bowel disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ibd\/izy232","article-title":"Frequency of herpes zoster vaccination among inflammatory bowel disease patients","volume":"25","author":"Khan","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cgh.2018.10.016","article-title":"Efficacy of live attenuated herpes zoster vaccine in patients with inflammatory bowel diseases","volume":"17","author":"Khan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","article-title":"Recombinant zoster vaccine (Shingrix((R))): a review in herpes zoster","volume":"35","author":"Syed","year":"2018","journal-title":"Drugs Aging"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/21645515.2018.1560918","article-title":"Immune responses to zoster vaccines","volume":"15","author":"Levin","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1016\/j.vaccine.2018.07.005","article-title":"Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States","volume":"36","author":"Curran","year":"2018","journal-title":"Vaccine"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"e025553","DOI":"10.1136\/bmjopen-2018-025553","article-title":"Public health impact model estimating the impact of introducing an adjuvanted recombinant zoster vaccine into the UK universal mass vaccination programme","volume":"9","author":"van Oorschot","year":"2019","journal-title":"BMJ Open"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12916-018-1213-5","article-title":"Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines","volume":"16","author":"de Boer","year":"2018","journal-title":"BMC Med"},{"key":"R38-20250504","first-page":"05","article-title":"Shingrix for herpes zoster: a review","volume":"24","author":"Shah","year":"2019","journal-title":"Skin Therapy Lett"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:01:09Z","timestamp":1746331269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026863"}},"subtitle":["A meta-analysis of cohort studies"],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":36,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026863","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"assertion":[{"value":"2021-01-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}